Development of topical formulation of sirna-nanoparticle for treating skin diseases
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43TR001906
- Recipient
-
PDX Pharmaceuticals Inc. UEI VTX7JRKLC3F5
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $325,000
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date
- Originally
- Place of performance
- Portland, OR 97239, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $325,000 |
Quick answers
Who received award R43TR001906?
R43TR001906 was awarded to PDX Pharmaceuticals Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on August 15, 2017.
How much is award R43TR001906 worth?
$325,000 has been obligated on R43TR001906.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award